Evidence map›Paper›PMID 32099849›Full record

ArticleMolecular therapy. Methods & clinical development2020

Chromosome Transplantation: A Possible Approach to Treat Human X-linked Disorders.

Marianna Paulis, Lucia Susani, Alessandra Castelli, Teruhiko Suzuki, Takahiko Hara, Letizia Straniero, Stefano Duga, Dario Strina, Stefano Mantero, Elena Caldana and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Marianna PaulisNational Research Council (CNR)-IRGB/UOS, Milan, Italy.
Lucia SusaniNational Research Council (CNR)-IRGB/UOS, Milan, Italy.
Alessandra CastelliNational Research Council (CNR)-IRGB/UOS, Milan, Italy.
Teruhiko SuzukiStem Cell Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Takahiko HaraStem Cell Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Letizia StranieroDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.
Stefano DugaHumanitas Clinical and Research Center, Rozzano (MI), Italy.
Dario StrinaNational Research Council (CNR)-IRGB/UOS, Milan, Italy.
Stefano ManteroNational Research Council (CNR)-IRGB/UOS, Milan, Italy.
Elena CaldanaNational Research Council (CNR)-IRGB/UOS, Milan, Italy.
Lucia Sergi SergiSan Raffaele-TIGET, Milan, Italy.
Anna VillaNational Research Council (CNR)-IRGB/UOS, Milan, Italy.
Paolo VezzoniNational Research Council (CNR)-IRGB/UOS, Milan, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITHumanitas University · ITNational Research Council · ITThe San Raffaele Telethon Institute for Gene Therapy · ITTokyo Metropolitan Institute of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many human genetic diseases are associated with gross mutations such as aneuploidies, deletions, duplications, or inversions. For these "structural" disorders, conventional gene therapy, based on viral vectors and/or on programmable nuclease-mediated homologous recombination, is still unsatisfactory. To correct such disorders, chromosome transplantation (CT), defined as the perfect substitution of an endogenous defective chromosome with an exogenous normal one, could be applied. CT re-establishes a normal diploid cell, leaving no marker of the procedure, as we have recently shown in mouse pluripotent stem cells. To prove the feasibility of the CT approach in human cells, we used human induced pluripotent stem cells (hiPSCs) reprogrammed from Lesch-Nyhan (LN) disease patients, taking advantage of their mutation in the X-linked

Indexed as

chromosome transferchromosome transplantationgenetic therapygenomic disordersinduced pluripotent stem cells

Identifiers

PMID32099849
PMCPMC7029378
OpenAlexW3000849293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.